These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23965125)

  • 1. Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series.
    Taldone T; Patel PD; Patel M; Patel HJ; Evans CE; Rodina A; Ochiana S; Shah SK; Uddin M; Gewirth D; Chiosis G
    J Med Chem; 2013 Sep; 56(17):6803-18. PubMed ID: 23965125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establish an automated flow injection ESI-MS method for the screening of fragment based libraries: Application to Hsp90.
    Riccardi Sirtori F; Caronni D; Colombo M; Dalvit C; Paolucci M; Regazzoni L; Visco C; Fogliatto G
    Eur J Pharm Sci; 2015 Aug; 76():83-94. PubMed ID: 25952103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic studies on Hsp90 inhibition by ansamycin derivatives.
    Onuoha SC; Mukund SR; Coulstock ET; Sengerovà B; Shaw J; McLaughlin SH; Jackson SE
    J Mol Biol; 2007 Sep; 372(2):287-97. PubMed ID: 17662999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90.
    He H; Zatorska D; Kim J; Aguirre J; Llauger L; She Y; Wu N; Immormino RM; Gewirth DT; Chiosis G
    J Med Chem; 2006 Jan; 49(1):381-90. PubMed ID: 16392823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of aminoquinolines as a new class of potent inhibitors of heat shock protein 90 (Hsp90): Synthesis, biology, and molecular modeling.
    Ganesh T; Min J; Thepchatri P; Du Y; Li L; Lewis I; Wilson L; Fu H; Chiosis G; Dingledine R; Liotta D; Snyder JP; Sun A
    Bioorg Med Chem; 2008 Jul; 16(14):6903-10. PubMed ID: 18571929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Isoform-Selective Ligands for the Middle Domain of Heat Shock Protein 90 (Hsp90).
    Mak OW; Chand R; Reynisson J; Leung IKH
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and biological testing of peptidic dimerization inhibitors of human Hsp90 that target the C-terminal domain.
    Bopp B; Ciglia E; Ouald-Chaib A; Groth G; Gohlke H; Jose J
    Biochim Biophys Acta; 2016 Jun; 1860(6):1043-55. PubMed ID: 26774645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.
    Ge J; Normant E; Porter JR; Ali JA; Dembski MS; Gao Y; Georges AT; Grenier L; Pak RH; Patterson J; Sydor JR; Tibbitts TT; Tong JK; Adams J; Palombella VJ
    J Med Chem; 2006 Jul; 49(15):4606-15. PubMed ID: 16854066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragment-based drug discovery applied to Hsp90. Discovery of two lead series with high ligand efficiency.
    Murray CW; Carr MG; Callaghan O; Chessari G; Congreve M; Cowan S; Coyle JE; Downham R; Figueroa E; Frederickson M; Graham B; McMenamin R; O'Brien MA; Patel S; Phillips TR; Williams G; Woodhead AJ; Woolford AJ
    J Med Chem; 2010 Aug; 53(16):5942-55. PubMed ID: 20718493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the Hsp90 cochaperone cyclophilin 40 with Hsc70.
    Carrello A; Allan RK; Morgan SL; Owen BA; Mok D; Ward BK; Minchin RF; Toft DO; Ratajczak T
    Cell Stress Chaperones; 2004; 9(2):167-81. PubMed ID: 15497503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a mitochondria-targeted Hsp90 inhibitor based on the crystal structures of human TRAP1.
    Lee C; Park HK; Jeong H; Lim J; Lee AJ; Cheon KY; Kim CS; Thomas AP; Bae B; Kim ND; Kim SH; Suh PG; Ryu JH; Kang BH
    J Am Chem Soc; 2015 Apr; 137(13):4358-67. PubMed ID: 25785725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a fluorescence polarization assay for the molecular chaperone Hsp90.
    Kim J; Felts S; Llauger L; He H; Huezo H; Rosen N; Chiosis G
    J Biomol Screen; 2004 Aug; 9(5):375-81. PubMed ID: 15296636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer.
    Brough PA; Aherne W; Barril X; Borgognoni J; Boxall K; Cansfield JE; Cheung KM; Collins I; Davies NG; Drysdale MJ; Dymock B; Eccles SA; Finch H; Fink A; Hayes A; Howes R; Hubbard RE; James K; Jordan AM; Lockie A; Martins V; Massey A; Matthews TP; McDonald E; Northfield CJ; Pearl LH; Prodromou C; Ray S; Raynaud FI; Roughley SD; Sharp SY; Surgenor A; Walmsley DL; Webb P; Wood M; Workman P; Wright L
    J Med Chem; 2008 Jan; 51(2):196-218. PubMed ID: 18020435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Hsp90 C-terminal domain to induce allosteric inhibition and selective client downregulation.
    Goode KM; Petrov DP; Vickman RE; Crist SA; Pascuzzi PE; Ratliff TL; Davisson VJ; Hazbun TR
    Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):1992-2006. PubMed ID: 28495207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inside the Hsp90 inhibitors binding mode through induced fit docking.
    Lauria A; Ippolito M; Almerico AM
    J Mol Graph Model; 2009 Feb; 27(6):712-22. PubMed ID: 19084447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors.
    Baruchello R; Simoni D; Marchetti P; Rondanin R; Mangiola S; Costantini C; Meli M; Giannini G; Vesci L; Carollo V; Brunetti T; Battistuzzi G; Tolomeo M; Cabri W
    Eur J Med Chem; 2014 Apr; 76():53-60. PubMed ID: 24565573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation of the Non-Selective Aminocyclohexanol-Based Hsp90 Inhibitor into a Grp94-Seletive Scaffold.
    Mishra SJ; Ghosh S; Stothert AR; Dickey CA; Blagg BS
    ACS Chem Biol; 2017 Jan; 12(1):244-253. PubMed ID: 27959508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future.
    Gewirth DT
    Curr Top Med Chem; 2016; 16(25):2779-91. PubMed ID: 27072700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a new series of potent diphenol HSP90 inhibitors by fragment merging and structure-based optimization.
    Ren J; Li J; Wang Y; Chen W; Shen A; Liu H; Chen D; Cao D; Li Y; Zhang N; Xu Y; Geng M; He J; Xiong B; Shen J
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2525-9. PubMed ID: 24751441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of natural and synthetic inhibitors to human heat shock protein 90 and their clinical application.
    Petrikaitė V; Matulis D
    Medicina (Kaunas); 2011; 47(8):413-20. PubMed ID: 22123555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.